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Introduction: The kidney’s capacity to increase its glomerular filtration rate (GFR) in response to a higher
functional demand is known as the renal functional reserve (RFR). Good short-term outcomes after living
kidney donation have led to more acceptance of borderline donors (with hypertension, obesity, older age)
due the ongoing shortage of donor organs. Given recent concerns about increased long-term risk in some
donor subgroups, better donor stratification is needed. Measurement of RFR could inform assessment of
donor risk.
Methods: A systematic literature review of studies that assessed RFR in donors pre- and/or post-donation
was performed. Given study heterogeneity, descriptive analysis and narrative synthesis was conducted.
Results: Sixteen of 3250 identified studies published between 1956 and 2019 met inclusion criteria. Most
studies were cross-sectional and conducted before (n ¼ 8) and/or after (n ¼ 16) kidney donation. Methods
for measurement of GFR, effective renal plasma flow (ERPF) and RFR were not standardized. Changes in
filtration fraction (FF) and ERPF relative to GFR observed after donation varied depending on stimulus used
to induce RFR. Overall, RFR fell after donation; however, over the shorter term, RFR was largely preserved
in young healthy donors. RFR was more significantly reduced in donors with hypertension, obesity, or
older age.
Conclusion: Existing data suggest possible blunting of RFR post-donation in older, obese, and hyperten-
sive donors, which may represent increased single-nephron GFR at baseline. The long-term implications
of these changes deserve further study to determine utility in informing selection of borderline kidney
donors.
Kidney Int Rep (2020) 5, 448–458; https://doi.org/10.1016/j.ekir.2019.12.021
KEYWORDS: borderline kidney donors; glomerular filtration rate; kidney function; living kidney donation; nephron;
renal functional reserve
ª 2020 International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
K
idney transplantation confers a better quality of
life and better survival compared with dialysis
and is more cost-effective over the long-term.1 Living
kidney donation presents an important source of or-
gans given the shortage of deceased donor kidneys.
Growing confidence, based on satisfactory short- and
long-term outcomes in living kidney donors (LKDs),
has led to the inclusion of more borderline donors
(i.e., older age, controlled hypertension, low-grade
proteinuria, body mass index [BMI] up to 35).2 In
addition, the final decision of the transplant nephrolo-
gist in living donor selection is still highly dependent
on estimated GFR, which is, however, not an ideal
method to determine actual kidney function given
the known factors affecting its accuracy (e.g., protein
intake, muscle mass, physical activity, age, sex).
Recent studies have highlighted poorer long-term out-
comes in certain donor populations, such as those of
African American or indigenous origin and obese do-
nors.3–5 As all donors are generally well screened
before donation, routine clinical parameters alone
(blood pressure, urine protein, kidney function,
body mass/size at the time of donation) have not
been robust predictors of long-term risk in such donor
populations.5 Final acceptance of a living donor is,
however, still highly dependent on GFR, which may
be affected by multiple nonrenal factors (e.g., protein
intake, muscle mass, physical activity, age, gender),
and which when estimated, tends to underestimate
measured GFR in LKDs.6,7
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After nephrectomy, the single kidney undergoes an
adaptive increase in function of approximately 35%.5,8,9
This capacity of a kidney to increase its GFR when there
is a higher functional demand is recognized as the renal
functional reserve (RFR).10 Experimental data on 11 of 12
nephrectomies in rats indicate that hyperfiltration
driven by glomerular hypertension leads to progressive
kidney failure.11,12 How relevant these data are in the
case of a 50% loss of nephron mass in healthy LKDs is
not clear given the general long-term safety of living
kidney donation; however, this paradigm may be more
applicable to borderline kidney donors.
Static measurement of GFR does not capture RFR or
whether the single-nephron GFR (SNGFR) is already
elevated at baseline (i.e., already using the RFR for
baseline function). Measurement of RFR (most
commonly induced by protein or amino acid loading or
dopamine infusion) can be considered a renal stress
test, which can assist in determining whether a kidney
has the capacity to increase its baseline function or
not.9 Such information could inform decisions on
whether donation of a kidney in an individual donor
would be acceptable or not, within the context of other
risk factors, and may be useful in prospective studies
to determine whether the pre-donation RFR can predict
stability of long-term kidney function post-donation in
borderline candidates. Although RFR testing has been
established for decades and makes physiologic sense, it
has not entered into routine clinical practice, in part
because it is cumbersome and in part because the true
clinical impact and utility have not been rigorously
studied.9 Challenges in extrapolating results across
different methodologies and simultaneous inclusion of
diverse patient groups has also likely hampered un-
derstanding and interpretation of studies on RFR.
Given the increasing need for organs and the practice
of accepting more borderline donors, there is an obli-
gation for the kidney transplant community to develop
tools to better predict the longer-term risk in potential
donors.
We conducted a systematic review of studies that
measured RFR in LKDs, to describe patterns in higher-
risk donor subgroups before and after kidney dona-
tion, and to investigate potential associations with
long-term kidney function. The underlying aim of the
study was to better understand the potential clinical
value of RFR measurement in borderline kidney do-
nors, and thus its utility in informing donor selection.
METHODS
Search Strategy and Selection Criteria
A systematic literature review was performed based on
the Preferred Reporting Items for Systematic Reviews
and Meta-Analysis (PRISMA) guidelines.13 PubMed,
EBSCO, and Web of Science were searched from
January 1, 1956, up to January 26, 2019, using the
following search terms: kidney function glomerular
filtration rate OR renal functional reserve capacity OR
renal blood flow AND kidney donor (PubMed), kidney
function glomerular filtration rate AND renal functional
reserve capacity OR renal blood flow AND kidney donor
(EBSCO, Web of Science). Studies were restricted to the
English language and were included for analysis if they
reported RFR in living donors both before and/or after
kidney donation. Studies that did not evaluate post-
donation RFR were excluded, as they did not permit
assessment of RFR in the remaining kidney after living
kidney donation. Studies also were excluded if per-
formed in animals and in recipients of deceased donor
organs. Two authors (VAL and AF) independently
screened titles and abstracts and studies fulfilling in-
clusion criteria were analyzed in full text.
Quality Assessment and Data Extraction
Study quality was assessed independently by 2 authors
(VAL and AF) using the Critical Appraisal Skills Pro-
gramme (CASP) checklist for case-control studies.14
Studies were considered of low quality if measure-
ment of RFR did not use an established method (section
A), precision of RFR test method was questionable with
wide variability in low subject numbers (section B), or
the results may not have been generalizable (section C).
Minor disagreements were discussed and a consensus
achieved in discussion with author TM. Studies were
deemed of low quality if RFR measurements were not
standardized and/or results were highly variable across
small subject numbers or included subjects not likely
to be representative of the larger donor group. Data
from studies meeting acceptable quality (e.g., inclusion
of detailed methodology used for GFR and RFR mea-
surements, as well as analyzing potential confounding
factors) and inclusion criteria were extracted into
Microsoft Excel. AF performed initial data extraction,
which was verified independently by VL and TM.
Data Analysis
Given the heterogeneity of studies with regard to study
population, method of measurement of RFR and timing
of testing pre– and post–kidney donation, a descriptive
analysis with narrative synthesis was performed. Pre-
and post-donation data in the same subjects were
analyzed in 8 studies. Post-donation RFR was analyzed
in all 16 studies. RFR findings were stratified by donor
characteristics (age, sex, BMI) where described. Data on
long-term kidney function (>5 years post-donation)
were extracted when reported.
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RESULTS
A total of 3250 studies were identified through the
literature search terms (Figure 1). Of these, 23 studies
were considered for final analysis. Five studies were
excluded because they did not measure RFR post-
donation, 2 were excluded for low quality, 1 of
which included only 2 living donors, and 1 that used
an unconventional method to measure RFR, results
were highly variable and a minority of eligible patients
were included. Sixteen studies therefore fulfilled the
inclusion criteria. All studies reported RFR measure-
ment post-donation, 8 studies included both pre- and
post-donation measurements (Table 115–29). In total,
RFR measurements were reported for 1547 donors,
whereas both pre- and post-donation data were avail-
able for 1425 donors.
Methods Used to Assess GFR and ERPF
Methods used for GFR and RFR measurements with
changes in GFR, ERPF, RFR, and FF are presented in
Table 1. Six studies15–20 assessed GFR using creatinine
clearance, all before or including 1986, and 11 studies
used exogenous marker clearance, from 1986 onward.
One study used both creatinine and inulin clearance.16
Radiolabeled iothalamate was used in 8 studies,21–28
and diethylenetriamine pentaacetic acid was used in 1
Figure 1. PRISMA flow diagram. RFR, renal functional reserve.
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131I-hippurate Dopamine 1.5 mg/kg
per min
4/3 114/124 72/75 378/450 256/291 31/28 29/26 9/3 19/14
383 Subgroup with
long-term data
4/5.1 yr 116/126 78/ND 407/496 263/ND 29/25 30/ND 9/ND 22/ND
van Londen,
201827
105 Female donors 125I-
iothalamate
131I-hippurate Dopamine 1.5 mg/kg
per min
4/2 118/128 76/80 405/496 286/322 30/26 27/25 8/5 22/11
Tent, 201225 47 Hypertensive 125I-
iothalamate
131I-hippurate Dopamine 1.5 mg/kg
per min
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131I-hippurate Dopamine 1.5–2 mg/
kg per min
—/3 114a/129a 68/72a 441a/600a 274a/344a 26/21 25/21 13/6 36/26
Chan,
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George,
199629
9 All DTPA — Oral
protein
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AA, amino acid; DG, data presented only as a graph, numbers not extractable; DTPA, diethylenetriamine pentaacetic acid; ERPF, effective renal plasma flow; FF, filtration fraction; GFR, glomerular filtration rate; NA, not applicable; ND, not done; PAH,
paraaminohippurate; RFR, renal functional response.






























































































study.29 Inulin, gold standard for GFR measurement,
was used only in 2 studies.16,30 Overall, the measured
GFR levels before and after donation were similar across
the studies, creatinine clearance–based values were
slightly higher than iothalamate measurements, and
all indicated a fall in GFR of 35% (range, 33%–42%)
from pre- to post-donation. ERPF was measured in
9 studies by using radiolabeled hippurate infusion21–28
or para-aminohippurate.30 ERPF levels before and after
donation were in a similar range across the studies,
corresponding with the 35% fall in GFR, indicating
no overall change in FF from pre- to post-donation
(range, 29%–38%).
Stimuli Used to Induce Renal Functional
Reserve
Oral protein loading, either containing a fixed amount
of protein (60–150 g) or adjusted according to donor
body weight (1–1.2 g/kg), i.v. dopamine, amino acids
(AAs), or dopamine with AAs were variably used to
elicit the RFR across studies. Trends of the differential
physiologic effects of these substances on GFR and
renal perfusion are summarized in Table 2.15–30 Overall,
dopamine infusions appear to induce the RFR through
an increase in ERPF, relatively greater than the increase
in GFR, indication of a fall in FF. I.v. AA or oral protein
loading, in contrast, were associated with a greater
effect on GFR relative to ERPF, indicating an increase in
FF. The greatest effect on RFR was observed with co-
administration of dopamine and AA, which increased
GFR and ERPF in parallel. RFR protocols used in the
studies are summarized in Table 3.15–30
Determination of RFR
RFR was measured 4 months before donation in 4 of 8
studies, all done by the same group and following the
same protocol. Timing of RFR measurement pre-
donation in the remaining 4 studies was not reported.
The intervals between kidney donation and post-
donation RFR measurements were variable across the
16 studies, as shown in Table 1, ranging from 1 month
to 22 years. RFR is reported as the percent increase in
baseline GFR on stimulation of kidney function. The
percent change in post-donation RFR across studies
was variable, which could be partly explained by the
use of different methodologies for GFR measurement
and for GFR stimulation. Studies in which GFR was
measured by creatinine clearance showed higher RFR
(range, 8%–25%) when compared with those in which
clearance of an exogenous marker was used (range,
4%–8%) (Table 1).
Overall, the comparison between RFR pre- and post-
donation (8 studies) indicates that post-donation RFR is
reduced compared with the pre-donation (range,
12.5% up to 75.0% decrease from pre-donation value).
These studies predominantly used dopamine stimula-
tion. The use of protein or AA was associated with
greater increases in RFR after donation (ranges 8%–
25% for protein; 9%–10% for AA, and 16%–18% for
AA þ dopamine). Overall, the RFR is variably reduced
post-donation and may be modulated by donor age,
BMI, and sex. In some donors, RFR was preserved post-
donation (Table 415,18,28).
Donor Age and RFR
Three studies evaluated the impact of donor age at time
of kidney donation on RFR (Table 4). Rook et al.28
included pre- and post-donation data. Using
125I-iothalamate to measure GFR and i.v. dopamine as a
stimulus, this group showed that RFR at 2 months post-
donation was best preserved in the age group 21 to 45
years and showed a significant decline in subjects 54 to
75 years of age, not seen with the pre-donation RFR
(Table 4). Rodriguez et al.15 and Cassidy and Beck18
tested the RFR long-term after donation. They
applied similar cutoff age levels and measured post-
donation RFR only, using creatinine clearances and
oral protein loading. In these studies, RFR was rela-
tively preserved over the long-term; however, selection
bias cannot be excluded, as patient numbers were
extremely small. The oldest donors were aged 60 years
compared with 75 years in the larger study by Rook
et al.28 Overall, older age may blunt the RFR post-
donation, suggesting some utilization of renal func-
tional reserve at baseline. However, more long-term
data on renal functional adaptation and RFR are
needed to assess the impact of age on long-term kidney
function post-donation. Data regarding ERPF and FF
were not available in these studies, limiting analysis
and conclusions.
Donor Weight and RFR
Two studies26,28 analyzed the effect of BMI on RFR
before and after donation (Table 527,28). Both studies
used 125I-iothalamate for GFR measurement and dopa-
mine to induce the RFR. Overweight donors had higher
GFRs pre- and post-donation compared with normal-
weight donors, suggesting increase in SNGFR due to
body size and higher metabolic demand, although no
difference was observed in post-donation albumin-
uria.26,28 Donors with BMIs of $25 kg/m2 had a
significantly greater decline in RFR post-donation
compared with those with BMI <25 kg/m2, measured
at 2 months post-donation (Table 5). BMI correlated
inversely with post-donation RFR. In both studies, the
loss of RFR associated with nephrectomy was already
seen in relatively young donors (mean age between 41
and 52 years) with only a mild degree of obesity (BMI
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>25). The early study time point 2 to 3 months post-
donation in both studies does not permit conclusions
regarding the long-term implications.
Donor Sex and RFR
Two studies examined the impact of sex on post-
donation RFR (Supplementary Table S1). Tapson
et al.20 and Cassidy and Beck,18 using change in
creatinine clearance after an oral protein load, found
that female donors (40–54 years) may have a marginally
higher RFR post-donation compared with male donors
(40–55 years) at 1 to 22 years after donation (26% vs.
24% and 32% vs. 14%, respectively). Given the het-
erogeneity in these 2 studies, there is not enough data
to support potential differences in RFR after kidney
donation between male and female kidney donors.
Donor Hypertension and RFR
Tent et al.25 examined the change in RFR at 4 months
pre- and 2 months post-donation in hypertensive do-
nors using 125I-iothalamate and i.v. dopamine (Table 1).
RFR was not different (8% vs. 8% of baseline GFR) in
hypertensive and normotensive donors pre-donation,
but after kidney donation, RFR was lower in both
hypertensive and normotensive donors (1% vs. 3% of
baseline GFR). ERPF and FF were higher in hyperten-
sive donors both pre- and post-donation. Blood pres-
sure and renal function were similar in hypertensive
donors and controls at all time points. Given the small
differences in RFR and FF and the short period of
follow-up, conclusions as to the long-term impact of
donation on RFR and kidney function in hypertensive
donors cannot be drawn.
RFR Over the Long-term
There were no longitudinal studies comparing pre- and
long-term post-donation data on RFR. The largest study
with 5-year follow-up data on kidney function in 383
donors did not measure RFR post-donation.26 A few
studies that measured only post-donation RFR after 5
years or longer indicate a retained reserve capacity;
however, the numbers of subjects included are very
small, selection bias cannot be excluded (i.e., those who
did well), and pre-donation measurements for com-
parison are not available (Table 1).15,18,20,23,30
Table 3. Protocols for renal functional reserve testing in living kidney donors















30 min 3/4–6 Gold standard for GFR
measurement, usually
measured together with ERPF
Costs, need for infusion, more blood







100–200 ml/h Dopamine and/or
amino acid at constant
rate infusion
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Results affected by tubular secretion,
muscle mass, more blood sampling
in short period
ERPF, effective renal plasma flow; GFR, glomerular filtration rate.
Compiled from Rodriguez-Iturbe et al.,15 Herrera et al.,16 Loo et al.,17 Cassidy and Beck,18 Chan,19 Tapson et al.,20 ter Wee et al.,21–24 Tent et al.,25 van Londen et al.,26,27 Rook et al.,28
George et al.,29 and Englund et al.
Table 2. Stimulation methods for RFR testing and their physiological importance
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[, increase; [[, higher increase; [[[, highest increase; Y, decrease;4, no change; AA, amino acid; ERPF, effective renal plasma flow; FF, filtration fraction; GFR, glomerular filtration
rate; RFR, renal functional response.
aBased on 1 study (George et al.29).
Compiled from the following studies: Rodriguez-Iturbe et al.,15 Herrera et al.,16 Loo et al.,17 Cassidy and Beck,18 Chan,19 Tapson et al.,20 ter Wee et al.,21–24 Tent et al.,25 van Londen
et al.,26,27 Rook et al.,28 George et al.,29 and Englund et al.30
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Blood Pressure and Urine Protein Post-Donation
Cassidy and Beck18 found an increase in proteinuria 3
to 10 years post-donation (297 mg/24 hours compared
with 106 mg/24 hours pre-donation), but there was no
confirmed association between RFR and albuminuria
post-donation. In contrast, Tent et al.25 found no sig-
nificant proteinuria at 2 months and 5 years after
donation in hypertensive or healthy donors; however,
albuminuria was not available. Hypertensive donors
had higher pre- and post-donation GFR compared with
nonhypertensive donors (118 ml/min vs. 113 ml/min
and 73 ml/min vs. 70 ml/min, respectively).25 Mean
arterial pressures remained stable over 5 years in both
hypertensive and nonhypertensive donors.25
DISCUSSION
Analysis of RFR before and after living kidney dona-
tion suggests that RFR is reduced after kidney dona-
tion, and the reduction is relatively greater among
older, overweight, and possibly hypertensive donors.
The heterogeneity of methods used, the timing of
measurements, the overall small donor numbers, the
predominantly cross-sectional analyses, and most
important the lack of long-term data across the studies
limit comparison of findings and do not permit robust
conclusions regarding the value of RFR in informing
decision making for living kidney donation.
Donor safety, in particular long-term sufficient renal
function, is the key requirement in LKD organ trans-
plantation. Thorough donor evaluation and knowledge
about long-term consequences of uninephrectomy,
especially in borderline candidates, is therefore
extremely important. Post-donation healthy kidneys in-
crease their GFR by approximately 35%.8 Brenner and
colleagues11,12 demonstrated that a major loss of nephron
mass induces hyperfiltration, which when driven by
glomerular hypertension leads to progressive nephro-
sclerosis and kidney failure. This key paradigm in
nephrology questions safety and acceptability of living
kidney donation, a procedure characterized by a loss of
50% of nephrons and an adaptive increase in SNGFR.
Living donation has, however, appeared generally safe
over the long-term, although recent studies have high-
lighted a minor but significant risk for end-stage kidney
disease in LKDs when compared with adequately
matched healthy controls, especially among certain
subgroups, such as African American individuals and
those with elevated BMI.5,31–33 Given that more border-
line candidates are being considered for kidney donation,
their risks of kidney dysfunction over time may also
prove to be increased. Better risk-stratification pre-
donation could inform the challenging discussions with
potential donors where there is often inherent tension
between not doing harm, the limits of altruism, and
respecting autonomy. Theoretically, RFR measurement
could provide such relevant information.
The adaptive increase in SNGFR after kidney dona-
tion occurs due to hemodynamic and structural
changes of the remaining glomeruli.34 Because the in-
crease in filtration of the single nephron uses reserve
capacity to a certain degree, it may be expected that
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BMI, body mass index; GFR, glomerular filtration rate; NA, not available; pre, pre-donor nephrectomy; post, post-donor nephrectomy; RFR, renal functional response.
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with the loss of a significant amount of nephron mass
(post-donation) the remaining RFR will be lower.
Indeed, a higher baseline GFR pre-donation was
already seen in hypertensive and obese donors
compared with those without hypertension and non-
obese donors, suggesting the presence of hyper-
filtration, which may explain the observed tendency
toward a dampened RFR post-donation.25,27 A loss of
RFR was also seen in older donors,26,28 again suggesting
elevated SNGFR and a possible exhaustion of reserve
capacity at baseline. The question of the long-term
consequence of the loss of RFR and the mechanism
by which this increase in filtration is sustained cannot
be answered by the existing studies. This circumstance
could plausibly lead to more rapid progressive loss of
kidney function in the face of superimposed stress.35
Longitudinal measurements of GFR and ERPF
allowing for calculations of FF would permit discrimi-
nation of hemodynamic functional changes from
structural changes. It would be most interesting,
especially in borderline donors, to know whether a
long-term increase in SNGFR is sustained primarily by
maladaptive glomerular hypertension with possible
stress on the filtration barrier, or by glomerular hy-
pertrophy without significant changes in FF and pres-
sure gradients. Recent publications point toward benign
glomerular enlargement and adaptive hyperfiltration
with hyperperfusion and enlargement of the filtration
surface area in some donors.34,36–38 However, these
elegant functional and morphometric studies were
performed in healthy, predominantly Caucasian donors
without functional testing of RFR and only after a
medium-term follow-up period.
There is currently no ideal method to test RFR or for
clinical assessment of nephron mass. Ideal tests should
be robust, safe, easy to perform, and inexpensive,
making them feasible to perform in the clinical routine.
Clinically, GFR is usually estimated rather than
measured. Obstacles to measurements of GFR with the
gold standard method of inulin clearance include cost,
time, availability, and potential allergic reactions.
Comparable obstacles apply for alternative exogenous
markers (e.g., radiolabeled iothalamate, iohexol,
diethylenetriamine pentaacetic acid, EDTA), which also
require radiation exposure. Many RFR studies there-
fore have used the clearance of endogenous creatinine
instead,15,17,20,39 despite the fact that creatinine is not
only filtered but also secreted and thus estimates of
GFR and urine collections are subject to error. Herrera
et al.16 simultaneously measured inulin and creatinine
clearance before and after a protein meal. They showed
that both clearance methods detect a protein-induced
increase in GFR. The inulin and creatinine clearance
values correlated well for the baseline conditions
(pre-meal). The stimulated clearance (post-meal) was
relatively higher using the creatinine- compared with
the inulin-based method in healthy subjects, however,
likely due to the increase in tubular creatinine secre-
tion. This effect was not seen in subjects with chronic
kidney disease who might have lost their tubular
reserve capacity.28 Creatinine-based measurement may
therefore be subject to inherent variability and is
reliant on the adequacy of voided urine samples.
The most frequently used method to elicit the RFR
has been dopamine stimulation and 125I-iothalamate to
measure GFR.21–28 Van Londen et al.,26 using this
method, suggested that the pre-donation RFR is not
predictive of donor kidney function at 5 years and
therefore is not useful. This conclusion may be valid as
an aggregate; however, those studied at 5 years rep-
resented only 40% of the initial cohort and the donors
included in this study would generally be considered
low risk, having a mean age of 52  11 years, mean
BMI of 26  4, a mean systolic blood pressure of 127 
13, a prevalence of albuminuria of 3%, and were
largely Caucasian. In addition, dopamine alone may not
be the best stimulus to reflect full RFR and 5-year
follow-up is not long enough to determine kidney life
and disease progression.40,41
The physiologic increase in GFR after a protein load
has long been recognized.42 The peak GFR in healthy
humans is reached approximately 90 minutes after
ingestion.43,44 Good hydration and a resting state are
important for detection of this rise in GFR. When
comparing other stimuli used to induce the RFR, it has
been shown that AA infusions increase GFR more than
dopamine infusions, and both given together further
increase GFR (Tables 1 and 2). The greater loss of RFR
post-donation when using dopamine as a stimulus
compared with AA indicates different mechanisms of
induction of an increase in filtration and different ca-
pacities to elicit maximal SNGFR. The best method to
induce and measure RFR and the potential to predict
long-term kidney function post-donation remains un-
known. New techniques for GFR measurement (e.g.,
use of visible fluorescent injectate: rhodamine deriva-
tive and fluorescein carboxymethylated dextran)45
could make RFR testing easier and more accessible.
Standardized studies to answer these questions need
to be long-term, measure baseline and stimulated
filtration as well as renal blood flow before and at
regular intervals post-donation, use a robust exogenous
GFR marker, stimulate filtration with a significant
protein load (>1 g/kg body weight) rather than
inducing minor hemodynamic changes via dopamine,
focus on borderline patients with changes expected to
be detectable in the medium- to long-term, and include
subjects with diverse origins from multiple centers.
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The predictive value of the pre-donation RFR in
more marginal donors with higher ages, blood pres-
sures, and BMIs and of different ethnicities is not
known. The few studies reviewed here suggest that
older, obese, and hypertensive donors may have a
relative loss of RFR post-donation and therefore may be
at risk of long-term renal functional decline (Tables 4
and 5).15,18,26,28
This increased risk may be amplified in the face of
subsequent renal hits, such as development of diabetes,
worsening blood pressure, increasing weight, or
possibly an episode of acute kidney injury.8 Further-
more, the impact of donor birth weight or prematurity,
which are associated with nephron number, on RFR has
also not been studied.46,47 Subjects with low birth
weight are at risk of developing hypertension and
chronic kidney disease due to increased SNGFR with
their already lower nephron number.48 Small studies
have shown that donors with lower birth weights have
higher risks of developing hypertension, proteinuria,
and lower estimated GFR up to 60 months after ne-
phrectomy.49,50 As aging may be accelerated in subjects
born with low birth weights or preterm, especially if
they develop subsequent overweight or obesity,
determination of RFR in such a potential donor may be
clinically relevant.47
Women tend to have fewer nephrons than men, and
as yet unexplained, chronic kidney disease, but not
ESKD, in general is more prevalent among women.47
Whether the RFR is different between female and
male donors remains unknown. Only 2 studies
compared RFR post-donation between a small number
of male and female donors without showing significant
differences (Supplementary Table S1). Knowledge of
the RFR in a female donor may be especially relevant
for those who may still be planning a pregnancy or
who may be obese (both hyperfiltration states), as the
loss of RFR could contribute to hypertension, pre-
eclampsia, proteinuria, and worsening of the kidney
function during pregnancy, which are known to be
more common among female kidney donors.51,52
The major strength of this systematic review is that
to the best of our knowledge we have included all
studies reporting post–kidney donation measurement
of RFR. Stratification of studies by method is useful to
inform future study design and study interpretation
given the differing physiologic effects of the various
methods of stimulation. The small number of studies,
their cross-sectional nature, and the lack of long-term
follow-up, and lack of ethnic diversity are major limi-
tations here, which prevents true understanding of the
value of RFR in prediction of long-term function in
living donors. This weakness, however, is in itself a
strength, as it strongly highlights the need for good
prospective studies going forward. Given that studies
have tended to be performed by the same research
groups, it is possible that some studies have over-
lapping patient populations. Given that we have not
pooled data, have restricted our analysis to a narrative
review, and have stratified the findings by donor
category, the potential for overlap has been reduced or
eliminated (Tables 4 and 5 and Supplementary
Table S1).
Despite the priority of donor safety and hence the
need for in-depth functional assessment of living
donor kidneys pre- and post-donation, very few
studies were identified that measured GFR, ERPF, and
RFR over the past 6 decades. The existing data indi-
cate a loss of RFR in borderline donor candidates (i.e.,
older, hypertensive, or overweight donors). However,
long-term data are needed to understand the relevance
of these findings, and more specifically to identify the
threshold RFR below which donation may not be
safe in each of the borderline clinical states. Based
on the existing uncertainties, physiologic plausibility,
and potential to enhance safety of living donation,
we suggest that RFR testing should be further eval-
uated as a tool to complement the assessment of
borderline LKDs.
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